Abstract 5250: Method development and workflow optimization of a CTC-based biomarker assay to predict response to CDK4/6 inhibitors in HR+/HER2- breast cancer

Mantasha Tabassum, Meghana V. Trivedi, Mothaffar F. Rimawi et al.|Cancer Research|2026

Cited by 0